Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer - Related Studies

Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer

This study is ongoing, but not recruiting participants.

Study NCT00004256. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cancer-Related Problem/Condition
		Head and Neck Cancer

2	Additional conditions recognized in this trial
		Head and Neck Neoplasms
		Laryngeal Neoplasms

3	More general conditions related to this trial
		Laryngeal Diseases
		Neoplasms
		Neoplasms by Site
		Otorhinolaryngologic Diseases
		Otorhinolaryngologic Neoplasms
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms

4	Interventions listed in this trial
		sargramostim
		quality-of-life assessment
		radiation therapy

5	Sponsors listed in this trial
		Royal Marsden - London